Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
The discovery of chromosomal rearrangements involving the anaplastic lymphoma kinase (ALK) gene in non-small cell lung cancer (NSCLC) has stimulated renewed interest in oncogenic fusions as potential therapeutic targets. Recently, genetic alterations in ROS1 and RET were identified in patients with NSCLC. Like ALK, genetic alterations in ROS1 and RET involve chromosomal rearrangements that result in the formation of chimeric fusion kinases capable of oncogenic transformation. Notably, ROS1 and RET rearrangements are rarely found with other genetic alterations, such as EGFR, KRAS, or ALK. This finding suggests that both ROS1 and RET are independent oncogenic drivers that may be viable therapeutic targets. In initial screening studies, ROS1 and RET rearrangements were identified at similar frequencies (approximately 1%–2%), using a variety of genotyping techniques. Importantly, patients with either ROS1 or RET rearrangements appear to have unique clinical and pathologic features that may facilitate identification and enrichment strategies. These features may in turn expedite enrollment in clinical trials evaluating genotype-directed therapies in these rare patient populations. In this review, we summarize the molecular biology, clinical features, detection, and targeting of ROS1 and RET rearrangements in NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Self-citationPao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.025 · Cited by 2,317
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Shaw, A. T., Yeap, B. Y., Mino-Kenudson, M., Digumarthy, S. R., Costa, D. B., Heist, R. S., Solomon, B., Stubbs, H., Admane, S., McDermott, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6993 · Cited by 1,870
Self-citationDefects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., & Pachnis, V. (1994) · Nature · doi:10.1038/367380a0 · Cited by 1,614
Wells, S. A., Robinson, B. G., Gagel, R. F., Dralle, H., Fagin, J. A., Santoro, M., Baudin, E., Elisei, R., Jarzab, B., Vasselli, J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5040 · Cited by 1,559
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Bergethon, K., Shaw, A. T., Ignatius Ou, S.-H., Katayama, R., Lovly, C. M., McDonald, N. T., Massion, P. P., Siwak-Tapp, C., Gonzalez, A., Fang, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6345 · Cited by 1,555
Self-citationLarge-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466
The impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
RET, ROS1 and ALK fusions in lung cancer
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2658 · Cited by 1,320
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P., & Wells, S. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.851 · Cited by 1,303
Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81311-2 · Cited by 1,174
Defects in enteric innervation and kidney development in mice lacking GDNF
Pichel, J. G., Shen, L., Sheng, H. Z., Granholm, A.-C., Drago, J., Grinberg, A., Lee, E. J., Huang, S. P., Saarma, M., Hoffer, B. J., et al. (1996) · Nature · doi:10.1038/382073a0 · Cited by 1,168
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N. D., Kanchi, K. L., Maher, C. A., Fulton, R., Fulton, L., Wallis, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.024 · Cited by 1,146
Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Ports, G., Fusco, A., & Vecchiot, G. (1990) · Cell · doi:10.1016/0092-8674(90)90659-3 · Cited by 959
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Lipson, D., Capelletti, M., Yelensky, R., Otto, G., Parker, A., Jarosz, M., Curran, J. A., Balasubramanian, S., Bloom, T., Brennan, K. W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2673 · Cited by 869
Activation of a novel human transforming gene, ret, by DNA rearrangement
Takahashi, M., Ritz, J., & Cooper, G. M. (1985) · Cell · doi:10.1016/0092-8674(85)90115-1 · Cited by 854
KIF5B-RET fusions in lung adenocarcinoma
Kohno, T., Ichikawa, H., Totoki, Y., Yasuda, K., Hiramoto, M., Nammo, T., Sakamoto, H., Tsuta, K., Furuta, K., Shimada, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2644 · Cited by 834
GDNF signalling through the Ret receptor tyrosine kinase
Durbec, P., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M., Wartiowaara, K., Suvanto, P., Smith, D., Ponder, B., Costantini, F., Saarma, M., et al. (1996) · Nature · doi:10.1038/381789a0 · Cited by 811
Functional receptor for GDNF encoded by the c-ret proto-oncogene
Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.-S., Sieber, B.-A., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumäe, U., et al. (1996) · Nature · doi:10.1038/381785a0 · Cited by 796
Mutations of the RET proto-oncogene in Hirschsprung's disease
Edery, P., Lyonnet, S., Mulligan, L. M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fékété, C., Ponder, B. A. J., & Munnich, A. (1994) · Nature · doi:10.1038/367378a0 · Cited by 749
Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M., Kääriäinen, H., et al. (1994) · Nature · doi:10.1038/367377a0 · Cited by 700
Carlson, K. M., Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C. E., Wells, S. A., Goodfellow, P. J., & Donis-Keller, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1579 · Cited by 600
The transcriptional landscape and mutational profile of lung adenocarcinoma
Seo, J.-S., Ju, Y. S., Lee, W.-C., Shin, J.-Y., Lee, J. K., Bleazard, T., Lee, J., Jung, Y. J., Kim, J.-O., Shin, J.-Y., et al. (2012) · Genome Research · doi:10.1101/gr.145144.112 · Cited by 584
RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
Wang, R., Hu, H., Pan, Y., Li, Y., Ye, T., Li, C., Luo, X., Wang, L., Li, H., Zhang, Y., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.1477 · Cited by 546
Ju, Y. S., Lee, W.-C., Shin, J.-Y., Lee, S., Bleazard, T., Won, J.-K., Kim, Y. T., Kim, J.-I., Kang, J.-H., & Seo, J.-S. (2012) · Genome Research · doi:10.1101/gr.133645.111 · Cited by 484
Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
Drilon, A., Wang, L., Hasanovic, A., Suehara, Y., Lipson, D., Stephens, P., Ross, J., Miller, V., Ginsberg, M., Zakowski, M. F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0035 · Cited by 464
Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
Davies, K. D., Le, A. T., Theodoro, M. F., Skokan, M. C., Aisner, D. L., Berge, E. M., Terracciano, L. M., Cappuzzo, F., Incarbone, M., Roncalli, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0550 · Cited by 464
Takahashi, M., Buma, Y., Iwamoto, T., Inaguma, Y., Ikeda, H., & Hiai, H. (1988) · PubMed · Cited by 442
McDermott, U., Iafrate, A. J., Gray, N. S., Shioda, T., Classon, M., Maheswaran, S., Zhou, W., Choi, H. G., Smith, S. L., Dowell, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6186 · Cited by 399
RET Proto-Oncogene in the Development of Human Cancer
Eng, C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.380 · Cited by 339
Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer
Socinski, M. A., Novello, S., Brahmer, J. R., Rosell, R., Sanchez, J. M., Belani, C. P., Govindan, R., Atkins, J. N., Gillenwater, H. H., Pallares, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9303 · Cited by 323
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
Martelli, M. P., Sozzi, G., Hernandez, L., Pettirossi, V., Navarro, A., Conte, D., Gasparini, P., Perrone, F., Modena, P., Pastorino, U., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080755 · Cited by 317
Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma
Gu, T.-L., Deng, X., Huang, F., Tucker, M., Crosby, K., Rimkunas, V., Wang, Y., Deng, G., Zhu, L., Tan, Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015640 · Cited by 307
Rimkunas, V. M., Crosby, K. E., Li, D., Hu, Y., Kelly, M. E., Gu, T.-L., Mack, J. S., Silver, M. R., Zhou, X., & Haack, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3351 · Cited by 293
Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma
Marsh, D. J., Learoyd, D. L., Andrew, S. D., Krishnan, L., Pojer, R., Richardson, A., Delbridge, L., Eng, C., & Robinson, B. G. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.681503.x · Cited by 279
Lee, J. S., Hirsh, V., Park, K., Qin, S., Blajman, C. R., Perng, R.-P., Chen, Y.-M., Emerson, L., Langmuir, P., & Manegold, C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1709 · Cited by 230
Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers
Li, C., Fang, R., Sun, Y., Han, X., Li, F., Gao, B., Iafrate, A. J., Liu, X.-Y., Pao, W., Chen, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028204 · Cited by 230
Sonnenberg-Riethmacher, E., Walter, B., Riethmacher, D., Gödecke, S., & Birchmeier, C. (1996) · Genes & Development · doi:10.1101/gad.10.10.1184 · Cited by 219
Expression and rearrangement of the ROS1 gene in human glioblastoma cells.
Birchmeier, C., Sharma, S., & Wigler, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9270 · Cited by 219
Non–Small Cell Lung Cancer, Version 1.2015
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D’Amico, T. A., Demmy, T. L., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0176 · Cited by 212
Charest, A., Lane, K., McMahon, K., Park, J., Preisinger, E., Conroy, H., & Housman, D. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10207 · Cited by 211
Blumenschein, G. R., Gatzemeier, U., Fossella, F., Stewart, D. J., Cupit, L., Cihon, F., O'Leary, J., & Reck, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.0541 · Cited by 205
The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer
Acquaviva, J., Wong, R., & Charest, A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.07.006 · Cited by 199
Chipping away at the lung cancer genome
Pao, W., & Hutchinson, K. E. (2012) · Nature Medicine · doi:10.1038/nm.2697 · Cited by 192
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture
Santoro, M., Melillo, R. M., & Fusco, A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02289 · Cited by 190
Structure and Physiology of the RET Receptor Tyrosine Kinase
Ibanez, C. F. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009134 · Cited by 183
Suehara, Y., Arcila, M., Wang, L., Hasanovic, A., Ang, D., Ito, T., Kimura, Y., Drilon, A., Guha, U., Rusch, V., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0838 · Cited by 180
Targeting the RET Pathway in Thyroid Cancer
Wells, S. A., & Santoro, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2742 · Cited by 168
ROS1-Rearranged Lung Cancer: A Clinicopathologic and Molecular Study of 15 Surgical Cases
Yoshida, A., Kohno, T., Tsuta, K., Wakai, S., Arai, Y., Shimada, Y., Asamura, H., Furuta, K., Shibata, T., & Tsuda, H. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182758fe6 · Cited by 165
Charest, A., Wilker, E. W., McLaughlin, M. E., Lane, K., Gowda, R., Coven, S., McMahon, K., Kovach, S., Feng, Y., Yaffe, M. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1193 · Cited by 163
Yasuda, H., de Figueiredo-Pontes, L. L., Kobayashi, S., & Costa, D. B. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182570919 · Cited by 161
Hamatani, K., Eguchi, H., Ito, R., Mukai, M., Takahashi, K., Taga, M., Imai, K., Cologne, J., Soda, M., Arihiro, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0293 · Cited by 160
Leow, P., Soo, R. A., Soong, R., & Ou, S. I. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826baf83 · Cited by 156
Targeting RET Receptor Tyrosine Kinase Activation in Cancer
Phay, J. E., & Shah, M. H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0786 · Cited by 150
Matsushime, H., Wang, L., & Shibuya, M. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.3000-3004.1986 · Cited by 144
Novello, S., Scagliotti, G. V., Rosell, R., Socinski, M. A., Brahmer, J. R., Atkins, J., Pallarés, C., Burgess, R., Tye, L., Selaru, P., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605346 · Cited by 135
Identification of ROS1 rearrangement in gastric adenocarcinoma
Lee, J., Lee, S. E., Kang, S. Y., Do, I., Lee, S., Ha, S. Y., Cho, J., Kang, W. K., Jang, J., Ou, S. I., et al. (2013) · Cancer · doi:10.1002/cncr.27967 · Cited by 132
Shaw, A. T., Camidge, D. R., Engelman, J. A., Solomon, B., Kwak, E. L., Clark, J. W., Salgia, R., Shapiro, G. I., Bang, Y., Tan, W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.7508 · Cited by 129
Self-citationCharacterization of an Activated Human ros Gene
Birchmeier, C., Birnbaum, D., Waitches, G. M., Fasano, O., & Wigler, M. H. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3109 · Cited by 124
Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident
lto, T., Seyama, T., Iwamoto, S., Mizuno, T., Tronko, M. D., Komissarenko, I., Cherstovoy, E., Satow, Y., Takeichi, N., Dohi, K., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)93024-4 · Cited by 124
Crizotinib and Testing for ALK
Shaw, A. T., Solomon, B., & Kenudson, M. M. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0115 · Cited by 123
Self-citationJun, H. J., Johnson, H., Bronson, R. T., de Feraudy, S., White, F., & Charest, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3990 · Cited by 116
Transient and locally restricted expression of the ros1 protooncogene during mouse development.
Sonnenberg, E., Gödecke, A., Walter, B., Bladt, F., & Birchmeier, C. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04937.x · Cited by 107
Charest, A., Lane, K. M., McMahon, K., & Housman, D. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104137200 · Cited by 106
Identification of CCDC6-RET Fusion in the Human Lung Adenocarcinoma Cell Line, LC-2/ad
Matsubara, D., Kanai, Y., Ishikawa, S., Ohara, S., Yoshimoto, T., Sakatani, T., Oguni, S., Tamura, T., Kataoka, H., Endo, S., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182721ed1 · Cited by 102
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint
Marotta, V., Guerra, A., Sapio, M. R., & Vitale, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0499 · Cited by 101
A Patient with Lung Adenocarcinoma and RET Fusion Treated with Vandetanib
Gautschi, O. P., Zander, T., Aebersold, F., Strobel, K., Hirschmann, A., Aebi, S. P., & Diebold, J. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828a4d07 · Cited by 100
Birch, A. H., Arcand, S. L., Oros, K. K., Rahimi, K., Watters, A. K., Provencher, D., Greenwood, C. M., Mes-Masson, A.-M., & Tonin, P. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028250 · Cited by 97
Schoffski, P., Elisei, R., Müller, S., Brose, M. S., Shah, M. H., Licitra, L. F., Jarzab, B., Medvedev, V., Kreissl, M., Niederle, B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.5508 · Cited by 92
Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma
Charest, A., Kheifets, V., Park, J., Lane, K. M., McMahon, K., Nutt, C. L., & Housman, D. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242741799 · Cited by 91
Drosten, M., & Pützer, B. M. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0610 · Cited by 90
A High-Dimensional, Deep-Sequencing Study of Lung Adenocarcinoma in Female Never-Smokers
Kim, S. C., Jung, Y., Park, J., Cho, S., Seo, C., Kim, J., Kim, P., Park, J., Seo, J., Kim, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055596 · Cited by 81
Li, F., Feng, Y., Fang, R., Fang, Z., Xia, J., Han, X., Liu, X., Chen, H., Liu, H., & Ji, H. (2012) · Cell Research · doi:10.1038/cr.2012.27 · Cited by 81
Tessarollo, L., Nagarajan, L., & Parada, L. F. (1992) · Development · doi:10.1242/dev.115.1.11 · Cited by 78
The human c-ros gene (ROS) is located at chromosome region 6q16----6q22.
Nagarajan, L., Louie, E., Tsujimoto, Y., Balduzzi, P. C., Huebner, K., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6568 · Cited by 71
ROS receptor tyrosine kinase: a new potential target for anticancer drugs
El-Deeb, I. M., Yoo, K. H., & Lee, S. H. (2010) · Medicinal Research Reviews · doi:10.1002/med.20206 · Cited by 66
Mouse Model for ROS1-Rearranged Lung Cancer
Arai, Y., Totoki, Y., Takahashi, H., Nakamura, H. K., Hama, N., Kohno, T., Tsuta, K., Yoshida, A., Asamura, H., Mutoh, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056010 · Cited by 63
Mutation-associated fusion cancer genes in solid tumors
Kaye, F. J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0135 · Cited by 61
KIF5B‐RET fusions in Chinese patients with non–small cell lung cancer
Cai, W., Su, C., Li, X., Fan, L., Zheng, L.-M., Fei, K., & Zhou, C. (2013) · Cancer · doi:10.1002/cncr.27940 · Cited by 59
ROS1 Rearrangements in Lung Cancer: A New Genomic Subset of Lung Adenocarcinoma
Janne, P. A., & Meyerson, M. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.4197 · Cited by 50
RET Fusion Genes in Non–Small-Cell Lung Cancer
Chao, B. H., Briesewitz, R., & Villalona-Calero, M. A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8240 · Cited by 41
Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
Stumpfova, M., & Janne, P. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1812 · Cited by 31
Ou, S., Camidge, D. R., Engelman, J. A., Clark, J., Tye, L., Wilner, K. D., Stephenson, P. A., Varella‐Garcia, M., Iafrate, A. J., & Shaw, A. T. (2012) · Annals of Oncology · doi:10.1093/annonc/mds408 · Cited by 16
Self-citation
Cited by
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Self-citationSystemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer: A Review
Arbour, K. C., & Riely, G. J. (2019) · JAMA · doi:10.1001/jama.2019.11058 · Cited by 1,060
Cell death-based treatment of lung adenocarcinoma
Denisenko, T. V., Budkevich, I. N., & Zhivotovsky, B. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0063-y · Cited by 768
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2014.05.01 · Cited by 716
Johnson, T. W., Richardson, P. F., Bailey, S., Brooun, A., Burke, B. J., Collins, M. R., Cui, J. J., Deal, J. G., Deng, Y.-L., Dinh, D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500261q · Cited by 594
Metadata
- Authors
- Gainor, J. F., & Shaw, A. T.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06-28
- Volume
- 18
- Issue
- 7
- Pages
- 865-875
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2133668831
- Cited by
- 342
- References
- 88
- FWCI
- 19.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.